Rhythm Share Price

Rhythm Share Price

NASDAQ: RYTM | Mid Cap | Healthcare
$119.11
+$2.45 (2.10%) Last updated on 19 Nov, 2026 | 01:27 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Rhythm Stock Performance

Open
$115.76
Prev. Close
$116.67
Circuit Range
N/A
Day Range
$115.19 - $121.23
Year Range
$74.51 - $122.00
Volume
1,09,881
Average Traded
$118.46

Rhythm Share Price Today

As of 19 November 2026, Rhythm Pharmaceuticals, Inc.'s share price is $119.11. The stock opened at $115.76, compared to its previous close of $116.67. During today's trading session, Rhythm Pharmaceuticals, Inc.'s share price traded between $115.19 and $121.23, with an average price of $118.21. Over the past 52 weeks, the stock has recorded a high of $122.00 and a low of $74.51. In terms of performance, Rhythm Pharmaceuticals, Inc.'s share price has risen by 34.81% over the last six months and is up 9.17% on a year-on-year basis.

Rhythm Share Price Chart

Line chart of the Rhythm price trend over the selected period. The price rose overall, ranging from 115.05 to 121.23, ending at 119.11.
$115.19$121.23
L
Show Current Price
H

Rhythm Stock Fundamentals & Key Indicators

Market Cap
$7.74B
PE Ratio (TTM)
N/A
Dividend Yield
0.02%
EPS (TTM)
$-2.86
Revenue (TTM)
$189.76B
Return On Equity (TTM)
-98.39%
Profit Margin
-106.41%
Debt to Equity
0.51
Quarterly Earnings Growth YoY
13.29%

Rhythm Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$57.25$60.11$71.26$92.13
Net Profit-$48.84-$56.74-$50.36-$42.35
Net Profit Margin-85.31%-94.39%-70.67%-45.97%
Income ChangeN/A-16.18%11.24%15.91%

Rhythm Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$23.64$77.43$130.13$189.76
Net Profit-$181.12-$184.68-$264.57-$201.92
Net Profit Margin-766.16%-238.51%-203.31%-106.41%
Income ChangeN/A-1.97%-43.26%23.68%

Rhythm Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets13.2818.0724.4828.25
Current Assets466.92374.2308.27354.24
Total Assets480.2392.27332.75382.48
Non Current Liabilities104.23112.21107.7878.41
Current Liabilities105.94115.5255.239.81
Total Liabilities210.17227.72162.99118.22
Shareholders' Equity270.0321.73169.76264.26

Rhythm Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-115.68-113.88-136.16-173.43
Investing-137.15-48.17-5.6728.03
Financing217.96191.2474.37213.83

About Rhythm

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

Rhythm Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$93.58
$119.10
+28.72%
Oct 2026
$95.83
$92.53
-3.03%
Sep 2026
$106.20
$95.42
-15.31%
Aug 2026
$100.39
$112.67
+13.50%
Jul 2026
$113.03
$99.27
-10.52%
Jun 2026
$87.60
$110.93
+25.54%
May 2026
$81.28
$88.36
+8.48%
Apr 2026
$88.03
$81.45
-6.38%
Mar 2026
$90.18
$87.00
-6.28%
Feb 2026
$105.28
$92.83
-9.46%
Jan 2026
$107.08
$102.53
-4.29%
Dec 2025
$107.91
$107.13
-1.81%

Rhythm Share Price FAQs